Effects of a Western-type Diet on Colorectal Inflammation
1 other identifier
interventional
5
1 country
1
Brief Summary
This study will look at the inflammatory (changes usually associated with infection/injury to the body) and bowel permeability (bowel's ability to allow contents to enter the body) effects of a Western-style diet (high fat and low in calcium) and a prudent-style diet (low fat and high in calcium) on the colon (large bowel). This study may provide information to prevent colorectal cancer in a high-risk population
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for early_phase_1
Started Feb 2009
Shorter than P25 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2009
CompletedFirst Submitted
Initial submission to the registry
March 19, 2009
CompletedFirst Posted
Study publicly available on registry
March 20, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2010
CompletedJanuary 11, 2012
January 1, 2012
1 year
March 19, 2009
January 10, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Inflammation in the rectosigmoid epithelium
visit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
Secondary Outcomes (6)
Circulating endotoxin levels
visit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
Expression profiles of pro- and anti-inflammatory genes in rectosigmoid biopsies
visit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
Gut permeability
visit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
Inflammatory cytokines in the colorectal mucosa and serum
visit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
Luminal and adherent gut microbiota
visit 1, 30 days after the first dietary intervention and 30 days after the second dietary intervention
- +1 more secondary outcomes
Study Arms (2)
Western style diet
ACTIVE COMPARATORhigh-fat, low-calcium diet
Prudent diet
ACTIVE COMPARATORlow-fat, calcium-sufficient diet
Interventions
Subjects will be randomized to begin on either a WD or a PD for 30 + 3 days. Once that dietary intervention is complete, subjects will have a four (4) week wash-out period and then will be placed on the other dietary intervention for 30 + 3 days
Subjects will be randomized to begin on either a WD or a PD for 30 + 3 days. Once that dietary intervention is complete, subjects will have a four (4) week wash-out period and then will be placed on the other dietary intervention for 30 + 3 days
Eligibility Criteria
You may qualify if:
- Healthy male or post-menopausal ( 2 years after menopause or stopping HRT)healthy female subjects
- Age between 50 and 72 years
- At increased risk for colorectal cancer (this includes those have had a colorectal adenoma excised, or have a first or second degree relative with colorectal neoplasia).
You may not qualify if:
- Personal history of cancer other than non-melanoma skin cancer within the past 10 years
- History of hereditary non-polyposis colon cancer
- Intestinal malabsorption, inflammatory bowel disease
- Prior gastrointestinal surgery other than appendectomy or surgery of the esophagus
- Any excess bleeding or coagulation disorders
- Subjects taking anti-coagulants, sterol-binding resins, NSAIDs other than aspirin, \< 600mg per day, other study medications, or other multiple medications that might, in the view of the study physicians, alter colonic function or inflammation
- Total cholesterol greater than 240mg/dl, triglycerides \> 600mg, LDL-C \> 175
- Subjects with a history of coronary artery disease
- HIV positive subjects
- Subjects taking antibiotics, anti-diabetes, hormone replacement therapy, oral, transplanted or injected contraceptives (thyroid hormone therapy is permitted as long as the subject is euthyroid)
- Currently participating in other clinical studies or completed participation in other clinical studies within the last 30 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rockefeller University
New York, New York, 10065, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Swaroop Pendyala, MD
Rockefeller University
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 19, 2009
First Posted
March 20, 2009
Study Start
February 1, 2009
Primary Completion
February 1, 2010
Study Completion
February 1, 2010
Last Updated
January 11, 2012
Record last verified: 2012-01